Henry Schein

Henry Schein ROE

The Return on Equity (ROE) of Henry Schein (HSIC) as of Nov 4, 2026 is 12.27 %. In the previous year, Return on Equity (ROE) was 11.49 % — a change of 6.71% (higher).

ROE

12.27 %

YoY

6.71%

Last updated:

In 2025, Henry Schein's return on equity (ROE) was 12.27 %, a 6.71% increase from the 11.49 % ROE in the previous year.

The Henry Schein ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
18.10 USD
Jan 1, 2019
16.94 USD
Jan 1, 2020
12.01 USD
Jan 1, 2021
18.22 USD
Jan 1, 2022
15.61 USD
Jan 1, 2023
11.38 USD
Jan 1, 2024
11.49 USD
Jan 1, 2025
12.27 USD
The Henry Schein ROE history
YEARROEYoY
12.27 %+6.71%
11.49 %+0.99%
11.38 %-27.10%
15.61 %-14.30%
18.22 %+51.64%
12.01 %-29.10%
16.94 %-6.37%
18.10 %+25.22%
14.45 %-20.35%
18.14 %+9.24%
16.61 %+0.27%
16.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Henry Schein Stock analysis

What does Henry Schein do? Henry Schein Inc is a global provider of medical products and services for the healthcare industry based in Melville, New York. It was founded in 1932 by Henry Schein and has a long history of providing high-quality products and services for the healthcare industry. The company specializes in four core areas: medical products, services, medical software, and veterinary products. In the medical products area, Henry Schein distributes a wide range of medical products and equipment, including dental and orthodontic products, surgical instruments and supplies, medical laboratory equipment and supplies, and furnishings for practices. The company strives to offer its customers the best selection of medical products at a competitive price. Henry Schein also offers services aimed at making the work of healthcare providers easier. For example, the company provides services such as practice management software, online pharmacies, insurance, and billing services to optimize the operation of a medical or veterinary practice. Another important area of the company is medical software. Henry Schein offers an extensive range of software solutions for medical and veterinary practices, as well as hospitals and other medical facilities. The software facilitates tasks such as electronic medical records, appointment scheduling, and financial management, enabling practices and hospitals to operate more efficiently. Henry Schein has also specialized in the field of veterinary medicine, offering a wide range of products and services for veterinarians and animal clinics. The company distributes veterinary instruments, laboratory equipment, surgical instruments, and veterinary medications, and also provides services such as practice management software and veterinary billing. The company aims to provide its customers with a comprehensive range of products and services in a variety of areas. Henry Schein has established itself as an industry leader and is valued for its high quality and excellent customer service. Henry Schein is one of the most popular companies on Eulerpool.

ROE Details

Decoding Henry Schein's Return on Equity (ROE)

Henry Schein's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Henry Schein's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Henry Schein's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Henry Schein’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Henry Schein stock

Return on Equity (ROE) of Henry Schein is 12.27 % in 2025.

Return on Equity (ROE) of Henry Schein changed from 11.49 % to 12.27 %, representing a 6.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Henry Schein since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Henry Schein with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Henry Schein

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Henry Schein